Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Christian Cardoso Arruda"'
Autor:
Yara Dadalti Fragoso, Christian Cardoso Arruda, Walter Oleschko Arruda, Joseph Bruno Bidin Brooks, Alfredo Damasceno, Carlos Augusto de Albuquerque Damasceno, Alessandro Finkelsztejn, Juliana Finkelsztejn, Paulo Diniz da Gama, Maria Cristina Brandão Giacomo, Sidney Gomes, Marcus Vinicius Magno Goncalves, Andre Palma da Cunha Matta, Marilia Manprim de Morais, Enedina Maria Lobato de Oliveira, Yuna Ribeiro, Henry Koiti Sato, Carlos Bernardo Tauil
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 72, Iss 9, Pp 712-714 (2014)
Fingolimod is a new and efficient treatment for multiple sclerosis (MS). The drug administration requires special attention to the first dose, since cardiovascular adverse events can be observed during the initial six hours of fingolimod ingestion. T
Externí odkaz:
https://doaj.org/article/d06c93940b6144ccb01a7a79800388d9
Autor:
Fernanda Cenovicz, Chiu Braga, Edcarlo Solera, Christian Cardoso Arruda, Renato Nisihara, Felipe Alex Purkott Pucci, Guilherme Augusto de Souza Machado
Publikováno v:
Sao Paulo Medical Journal, Volume: 134, Issue: 4, Pages: 330-334, Published: AUG 2016
São Paulo Medical Journal, Vol 134, Iss 4, Pp 330-334
Sao Paulo Medical Journal v.134 n.4 2016
São Paulo medical journal
Associação Paulista de Medicina
instacron:APM
São Paulo Medical Journal, Vol 134, Iss 4, Pp 330-334
Sao Paulo Medical Journal v.134 n.4 2016
São Paulo medical journal
Associação Paulista de Medicina
instacron:APM
CONTEXT AND OBJECTIVE: Increased life expectancy among people with Down syndrome (DS) has introduced new environmental factors that may affect blood pressure (BP) and/or lead to obesity in this population. The aim here was to investigate BP levels an
Autor:
Joseph Bruno Bidin Brooks, Alfredo Damasceno, Christian Cardoso Arruda, Carlos Bernardo Tauil, Henry Koiti Sato, Yuna Ribeiro, Juliana Finkelsztejn, André Palma da Cunha Matta, Alessandro Finkelsztejn, Enedina Maria Lobato de Oliveira, Marcus Goncalves, Maria Cristina Brandao Giacomo, Marilia Manprim de Morais, Yara Dadalti Fragoso, Paulo Diniz da Gama, Carlos Augusto de Albuquerque Damasceno, Sidney Gomes, Walter Oleschko Arruda
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 72, Iss 9, Pp 712-714 (2014)
Arquivos de Neuro-Psiquiatria, Volume: 72, Issue: 9, Pages: 712-714, Published: SEP 2014
Arquivos de Neuro-Psiquiatria v.72 n.9 2014
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Arquivos de Neuro-Psiquiatria, Volume: 72, Issue: 9, Pages: 712-714, Published: SEP 2014
Arquivos de Neuro-Psiquiatria v.72 n.9 2014
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Fingolimod is a new and efficient treatment for multiple sclerosis (MS). The drug administration requires special attention to the first dose, since cardiovascular adverse events can be observed during the initial six hours of fingolimod ingestion. T